Adial Pharmaceuticals Warrant
ADILW
ADILW was delisted on the 27th of July, 2023.
2 hedge funds and large institutions have $4K invested in Adial Pharmaceuticals Warrant in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
33% less capital invested
Capital invested by funds: $6K → $4K (-$2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$2K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.05K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Ameriprise
Minneapolis,
Minnesota
| $3K | +$2K | +20,000 | +133% |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $1K | +$1.05K | +10,511 | +140% |
|
ADILW Hedge Fund Activity: Q3 2022 in Review
2 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q3 2022, worth a combined $4K — down 33% from $6K a quarter earlier.
Fund positioning in ADILW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Ameriprise, adding an estimated $2K.
- 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $4K of Adial Pharmaceuticals Warrant stock for Q3 2022, down 33% quarter-over-quarter.
- 0 funds opened new Adial Pharmaceuticals Warrant positions in Q3 2022 and 0 closed out.
- The largest Adial Pharmaceuticals Warrant buyer in Q3 2022 was Ameriprise, an estimated $2K added.
Based on aggregated 13F filings for Q3 2022.